Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 4453,17 zł, with a 24-hour trading volume of 9,63B zł. The asset's market cap is 3,97T zł, after moving 0.85% in the last day.
Tokenized Eli Lilly And Co is trading at 4487,32 zł, with a tokenized market cap of 175,26M zł and a 24-hour trading volume of 7,56M zł. The tokenized asset has moved 0.66% in the past 24 hours.